Cboe UK CHF
Basilea Pharmaceutica AG (BSLNZ.XC)
44.25
-0.10
(-0.23%)
At close: 4:19:57 PM GMT+1
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
257,764
173,289
220,848
247,267
Total Liabilities Net Minority Interest
176,765
183,291
241,562
305,874
Total Equity Gross Minority Interest
80,999
-10,002
-20,714
-58,607
Total Capitalization
176,911
85,453
110,646
35,937
Common Stock Equity
80,999
-10,002
-20,714
-58,607
Capital Lease Obligations
15,759
17,698
18,311
906
Net Tangible Assets
80,625
-10,550
-21,292
-59,239
Working Capital
175,353
104,553
100,514
66,658
Invested Capital
176,911
100,906
148,113
159,442
Tangible Book Value
80,625
-10,550
-21,292
-59,239
Total Debt
111,671
128,606
187,138
218,955
Net Debt
--
51,008
84,127
164,349
Share Issued
13,169.76
13,099.83
13,093.45
12,992.17
Ordinary Shares Number
12,089.67
12,001.67
11,951.30
11,842.03
Treasury Shares Number
1,080.09
1,098.16
1,142.14
1,150.13
12/31/2021 - 11/24/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade